Add to ORKGThe burden and quality of life of caregivers of sickle cell anemia patients taking hydroxyurea versus those not taking hydroxyure
Introduction: Sickle Cell Anaemia (SCA) is a common haemolytic disorder prevalent in Eastern Ghats r...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
Several controlled studies have evidenced good efficacy and short-term and mid-term safety profiles ...
Comment on “The burden and quality of life of caregivers of sickle cell anemia patients taking hydro...
Context: Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-oc...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed ...
Thesis (Master's)--University of Washington, 2022Background: Sickle cell disease (SCD) is one of the...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Abstract Background The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously...
Summary: Sickle cell disease (SCD) is a potentially devastating condition that is caused by an autos...
Sickle cell disease (SCD) is a rare, inherited blood disorder that affects approximately 100,000 Ame...
Although hemoglobin SC (HbSC) disease is usually considered less severe than sickle cell anemia (SCA...
OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle c...
BACKGROUND: Sickle cell anemia is a hemoglobinopathy caused by a mutation that results in the produc...
Introduction: Sickle Cell Anaemia (SCA) is a common haemolytic disorder prevalent in Eastern Ghats r...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
Several controlled studies have evidenced good efficacy and short-term and mid-term safety profiles ...
Comment on “The burden and quality of life of caregivers of sickle cell anemia patients taking hydro...
Context: Hydroxyurea increases levels of fetal hemoglobin (HbF) and decreases morbidity from vaso-oc...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Background: The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously showed ...
Thesis (Master's)--University of Washington, 2022Background: Sickle cell disease (SCD) is one of the...
Background: There are about 95,000 Americans living with sickle cell disease. The illness can lead t...
Abstract Background The Multicenter Study of Hydroxyurea (HU) in Sickle Cell Anemia (MSH) previously...
Summary: Sickle cell disease (SCD) is a potentially devastating condition that is caused by an autos...
Sickle cell disease (SCD) is a rare, inherited blood disorder that affects approximately 100,000 Ame...
Although hemoglobin SC (HbSC) disease is usually considered less severe than sickle cell anemia (SCA...
OBJECTIVE: The oxidative stress in 20 sickle cell anemia patients taking hydroxyurea and 13 sickle c...
BACKGROUND: Sickle cell anemia is a hemoglobinopathy caused by a mutation that results in the produc...
Introduction: Sickle Cell Anaemia (SCA) is a common haemolytic disorder prevalent in Eastern Ghats r...
Hydroxyurea has many characteristics of an ideal drug for sickle cell anemia (SCA) and provides ther...
Several controlled studies have evidenced good efficacy and short-term and mid-term safety profiles ...